For two centuries, the Tata name has symbolised Indian industry and philanthropy. But who exactly are Tata Sons? Who are the ...

Get Q3 2025 earnings insights on Kiniksa Pharmaceuticals: record ARCALYST sales, raised guidance, new drug milestones, and growth prospects.

Option Care Health Inc (OPCH) reports a robust 12% revenue increase, while navigating the impact of Stelara biosimilars and ...

Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net ...

Today's call will feature prepared comments by Will Lewis, Chair and Chief Executive Officer; Roger Adsett, Chief Operating Officer; and Sara Bonstein, Chief Financial Officer. After their comments, ...

In October 2025, Connie Britton announced her engagement to David Windsor after being together for six years. David Windsor ...

In response, the province says it will invest $50-million into adding support staff for family docs, $120-million into ...

Kiniksa Pharmaceuticals Ltd. Class A (($KNSA)) has held its Q3 earnings call. Read on for the main highlights of the call. Kiniksa Pharmaceuticals ...

Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...

Turn rules into automatic checks. Convert your business rules into a machine-readable checklist that runs every time someone ...

Artificial intelligence is making major advances in healthcare, science journalist David Pogue said Sunday at the Sinai Forum.